周度策略行业配置观点：政策支持+行业突破-2025-03-11

Group 1: Market Overview - The A-share market experienced a broad-based rally led by technology, with the Shanghai Composite Index rising by 1.55%, the Sci-Tech 50 up by 2.67%, the Shenzhen Component increasing by 2.19%, and the ChiNext Index gaining 1.61% during the week [1][9] - Daily trading volume reached a new high of 1.70 trillion yuan, indicating strong market activity concentrated in high-growth sectors such as AI, smart driving, and robotics [1][9] Group 2: Technology Sector Insights - The technology sector is driven by dual forces of AI computing power and data elements, with storage chips entering a price increase cycle, benefiting companies like Jiangbolong, which is positioned as a leader in the storage industry [2][21][22] - The connector market is also poised for growth, with companies like Hongrida benefiting from the demand for AIoT upgrades and increased orders from smart terminals [3][24] Group 3: High-end Manufacturing - The smart driving industry in China is rapidly developing, supported by policy initiatives and technological advancements, with expectations that by 2025, the penetration rate of high-level autonomous vehicles will exceed 70% [4][25] - The industry is witnessing a shift towards domestic chip production and the formation of a cloud-integrated ecosystem, with companies like BYD pushing advanced smart driving technology to more affordable models [4][25] Group 4: Mechanical and Industrial Automation - Increased infrastructure investment and domestic demand recovery are driving growth in the mechanical and industrial automation sectors, with a focus on intelligent and electric technologies reshaping the industry landscape [6][26] Group 5: Innovative Pharmaceuticals - The innovative drug sector is highlighted for its investment value, with Chinese pharmaceutical companies leveraging low-cost production and efficient R&D to enhance their global market share [7][27] - The sector is experiencing a shift towards original drug development, supported by policy reforms that accelerate the growth of biotech companies [7][27]